Home
Company Profile
SURGICAL ONCOLOGY
HIPEC – Hyperthermic IntraPeritoneal Chemotherapy
Isolated Organ Perfusion
Performer HT – Hyperthermic Perfusion
Publications
Congresses
Links
PRODUCTS
Performer 3
Performer HT
Instruction for use
SERVICES
Perfusion service
MULTIMEDIA
F.A.Q.
Contacts
LANGUAGE
Deutsch
Français
Español
Italiano
The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
Guyu Zhang, Yimin Zhu, Chongdong Liu, Guangming Chao, Ran Cui and Zhenyu Zhang
Prev
Next